NCT07331896 · University of Pittsburgh
Strategy Training for Optimizing Attention for Individuals With Spatial Neglect
(SOAR)
What this study is about
It is common for individuals after stroke to have a cognitive perceptual impairment called unilateral spatial neglect (neglect). Individuals with neglect have difficulty paying attention to one side of their body or one side of the environment and therefore experience difficulty performing daily activities.
View original scientific description
It is common for individuals after stroke to have a cognitive perceptual impairment called unilateral spatial neglect (neglect). Individuals with neglect have difficulty paying attention to one side of their body or one side of the environment and therefore experience difficulty performing daily activities. There are a lack of effective treatments for neglect and new interventions are needed to help reduce disability for these individuals. Metacognitive strategy training (strategy training) is an intervention that has the potential to reduce neglect-related disability and improve individuals' attention and awareness of their neglect. This study seeks to examine the effects of strategy training on neglect, self-awareness, and disability, specifically for individuals who are living in the community after their stroke.
Interventions
BEHAVIORAL
Strategy Training
This intervention will use an adapted form of strategy training for people with neglect.
BEHAVIORAL
Attention Control
This intervention will use a reflective listening protocol.
Primary outcome measures
Change in attention/neglect
Time frame: Baseline to Post-intervention (up to 60 days)
Change in attention/neglect measured with the Catherine Bergego Scale. Total scores on the Catherine Bergego Scale therapist-rated assessment range from 0-30 (higher=greater neglect). The a priori criterion for change was a medium effect size of change (Cohen's d≥0.5)
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- had a stroke
- presence of neglect as determined by score of \<18 or 2 or more collisions on the Virtual Reality Lateralized Attention Test (VRLAT); score below established cutoff for neglect on one of the six subtests of the Behavioral Inattention Test (BIT); OR reported signs/symptoms of neglect
- ≥18 years old
- lives within 30 miles of the University of Pittsburgh in a community dwelling.
Exclusion criteria
- Boston Diagnostic Aphasia Examination (BDAE) Severity Scale score of 0
- dementia per medical record
- active major depressive disorder per medical record
- not willing to be videotaped
- subject is currently receiving rehabilitation therapy as part of their usual care
Where
- Pittsburgh, Pennsylvania
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced May 12, 2026 · Source of record for eligibility and locations